Company / Operating Cash Flow
Forte Biosciences, Inc. Operating Cash Flow History
FY2018-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$31.1M
FY2019
5-year range
-$31.1M / -$29.5M
FY2018-FY2019
Trend
-5.4%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-$31M in FY2019.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, operating cash flow decreased 5.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | -$31.1M | -5.4% |
| FY2018 | -$29.5M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026